↓
 

Tag Archives: IASLC

Dr. Ben Solomon: A Journey from Sri Lanka to Zambia to Australia

Dr. Ben Solomon, thoracic oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia, recounts unique aspects of cancer care in Australia & his circuitous path from Sri Lanka to Zambia and Colorado before settling in Australia. (25:23)

Dr. Tony SK Mok: A Few Things You Probably Knew About Him, and a Bunch More You Didn’t

Dr. Tony Mok of the Chinese University of Hong Kong reflects with host Dr. Jack West on his circuitous career path that led him back to Hong Kong after training in Edmonton & Toronto, as well as the exciting career opportunities he has cultivated. (29:09)

Ivy Elkins & Jill Feldman (Pt 3): Patient Advocates Working with Physicians and Professional Societies

Lung cancer advocates Ivy Elkins and Jill Feldman talk with Dr. West about the role of cancer patient advocates working with researchers, attending professional conferences, as well as how different cultures manage a life-threatening cancer diagnosis. (21:23)

Dr. Lecia Sequist (Pt. 2): Post-ASCO Debrief & Efforts with IASLC

Lecia Sequist, MD, MPH of Massachusetts General Hospital & Harvard Medical School debriefs with host Dr. Jack West about key ASCO 2019 findings in EGFR mutation-positive NSCLC & her campaign for the IASLC Board of Directors. (23:57)

Dr. Heather Wakelee: Prioritizing Mentorship & Leadership in Thoracic Oncology

Drs. Heather Wakelee and Jack West review how she entered & became a leader in thoracic oncology, her prioritization of mentorship, & her efforts to continue the strong momentum of the International Association of the Study of Lung Cancer (IASLC). (30:27)

Dr. Giorgio Scagliotti: Shaping the Transformation of Thoracic Oncology

Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally. (17:42)

Dr. Joan Schiller: Changes in lung cancer management, leading a nonprofit, addressing stigma, & the rise of online patients

Drs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups. (19:07)

Dr. David Gandara: Cultivating Careers, Shaping Clinical Cancer Research, & Integrating Blood-Based Testing

Dr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers. (22:30)

Tumor Mutational Burden in Small Cell Lung Cancer: A Valuable Biomarker for Immunotherapy? (BMIC-011)

Dr. Jack West reviews new findings highlighting the utility of using the biomarker tumor mutation burden (TMB) to predict which patients with small cell lung cancer (SCLC) will benefit from nivolumab or the combination of nivolumab with ipilimumab. (9:08)

Download MP3 Audio Version

↑